Introduction
Infectious complications remain a serious problem of the posttransplant period and represent one of the main causes of adverse outcome.
The most common entries for the infection are the postoperative wound, the central venous catheter, the airways, and the urogenital tract. A number of factors giving rise to an increased susceptibility to infection include the virulence of microorganisms, the duration and the scheme of antibacterial prevention [1] .
With the active development of transplant services at the regional level, the problem of combating infectious complications is becoming increasingly important and requires the monitoring of the etiological structure and the general level of antibiotic resistance in each particular hospital dealing with this problem.
The microbial landscape of any medical institution results from a set of complex processes of interspecific micro-and macroorganism interrelationships occurring in a specific hospital environment, taking into account the influence of many aggressive environmental factors (physical and chemical disinfection methods, antibiotics). Bacteria exposed to the selective pressure of environmental factors acquire new properties: the resistance to external influences, increased virulence, resistance to antibacterial drugs, etc. [2 -4] .
Examples of microorganisms that present a particular problem worldwide in terms of the growth of antibiotic resistance are the representatives of the so-called ESKAPE group (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.) [5, 6] .
The results of the long-term monitoring of nosocomial infection pathogens in the intensive care unit (ICU) have demonstrated that currently dominating microorganisms are Gram-negative non-fermenting bacteria, namely P. aeruginosa and A. baumannii; Gram-negative microorganisms of the Enterobacteriaceae family, which produce extended-spectrum β-lactamases, and methicillin-resistant S. aureus and mixed infection [7] .
According to the Healthcare Ministry of the Russian Federation, the number of registered nosocomial infection cases was 56,000; and according to calculated data, there should be about 2.5 million [8] . Of great concern is the constant increase in the proportion of resistant strains among the main nosocomial pathogens. Thus, in multicenter Russian studies conducted in previous years, the frequency of methicillin-resistant strains of S. aureus and up to 54.8% in ICUs [9 ] . Pseudomonas aeruginosa is already multiresistant in most cases [10] .
Infectious complications developing during the immunosuppression administered after organ transplantation often have an atypical course, which create difficulty for making a timely diagnosis and initiating the etiotropic therapy [11] .
The problem of antibiotic resistance arose as early as around the 1940s of the 20th century, but in the past few decades it became rampant [12] . The problem of bacteria antibiotic resistance in the Republic of Belarus is not new either. Over the recent 3-4 years, there has been a relative decrease in antibiotic resistance, but there is a clearly seen tendency to an increased resistance of clinically significant bacteria to III-IV generation cephalosporins, carbapenems, which consumption has increased significantly. Therefore, the issue of optimizing the rational use or limiting the use of antibacterial drugs is relevant [13] .
Nosocomial infections develop in 5-15 % of in-hospital patients. The ICU patients are at the highest risk of their development, the incidence of such infections among them is 5-10 times higher compared to the patients in other hospital departments [14] .
The severity of patient's condition is the cause of a greater (almost 10 times) consumption of antimicrobial drugs in the ICU compared to other hospital departments [15] . Over 60% of ICU patients usually receive antibacterial therapy with the most commonly used broad-spectrum antibiotics or a combination of several antimicrobial agents [16] . An intensive use of the broad-spectrum drugs contributes to the emergence and spread of antibiotic resistance among nosocomial pathogens [17] .
The spread of the pathogenic bacteria resistant to antibiotics results in a steady growth of bacteria-associated diseases, which used to be successfully cured quite recently. Thus, the mortality rates for sepsis and pneumonia have acutely increased, since their pathogens have become resistant to the most common antibacterial drugs [18, 19] . 
Material and methods
The study included 37,103 patients admitted in the Vitebsk Regional Student's t-test was used to determine the difference significance. The differences were considered statistically significant at p <0.05.
Results and discussion
Negative results were obtained in 16,823 cases, of which 3826 (22.7%) cases accounted for ICU. During the study period, 20,280 isolates of various locations were investigated. The highest number of isolates was obtained from urine (9791; 48.2%) and sputum (6530; 32.2%).
Gram-negative flora prevailed in the general structure, making up 56.2% of isolates, mainly, K. pneumoniae (1758 isolates; 8.67%), P. aeruginosa (2896; 14.28%), A. baumannii (1449; 7.14%), E. coli (2287; 11.28%), P. mirabilis (267 isolates; 1.32%), E. faecium (829; 4.09%), and E. Table 1 . Table 2 . of isolates in 2017, respectively, due to the specific antimicrobial activity of this β-lactamase inhibitor. Noteworthy is the retained 100% sensitivity of A.
baumannii to the colistat action. Carbapenems had a low activity against A.
baumannii: only 10.7% of the isolates were sensitive to imipenem, 6% of the isolates were sensitive to meropenem in 2017. Almost all isolates found in the study period were resistant to cephalosporins and fluoroquinolones. Only 2.6% of Acinetobacter isolates were susceptible to amikacin.
Isolates of P. aeruginosa studied in 2015-2017 manifested a high resistance rate to all classes of antibiotics.
The dynamics of P. aeruginosa (n=970) sensitivity to the antibacterial drugs used in the ICU in the period 2015-2017 is presented in Table 4 . A serious problem for ICU in 2017 was the prevalence of K.
pneumoniae isolates serving as producers of extended-spectrum betalactamase and resistant to natural and semi-synthetic penicillins, cephalosporins of I-IV generation, and also to carbapenems, the resistance to which could be explained by the presence of the bla NDM and bla oxa-48 genes. It is important that the part of the gene encoding the extendedspectrum beta-lactamase synthesis is responsible for the mechanisms of resistance not only to cephalosporins, but also to other classes of antibiotics, primarily, to aminoglycosides and fluoroquinolones [21] . Sensitivity of K.
pneumoniae (n = 687) in the ICU patients in the period 2015-2017 is presented in Table 5 . Table 6 . on the obtained results, according to which all S. aureus isolates were susceptible to linezolid, vancomycin, and teicoplanin, while P. aeruginosa was susceptible to colistin. All isolates of Acinetobacter spp. were susceptible to colistin and 80% of isolates were susceptible to sulbactam.
Over 95% of K. pneumonia isolates were susceptible to tigecycline and colistin.
3. Due to an active development of transplant programs in our country, the use of immunosuppressive therapy, and the growth of infectious complications in recent times, there is a need to monitor the etiological structure and overall level of antibiotic resistance in medico-prophylactic institutions that perform organ transplantation.
